Why the study?
Does the identification of genetic factors improve the prediction of anthracycline-induced cardiotoxicity risk?
Does the identification of genetic factors improve the prediction of anthracycline-induced cardiotoxicity risk?
Identifying genetic susceptibility factors may enhance the prediction of anthracycline-induced cardiotoxicity risk beyond standard clinical factors.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: